Safety and Efficiency of Denosumab in Pediatric Subjects With Glucocorticoid-induced Osteoporosis

NCT03164928 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Evaluate the Safety and Efficacy of Denosumab in Pediatric Subjects With
Glucocorticoid-induced Osteoporosis

Interventions

DRUG: Denosumab
OTHER: Placebo

Sponsor

Amgen